Page last updated: 2024-10-28

hexoprenaline and Embryopathies

hexoprenaline has been researched along with Embryopathies in 1 studies

Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.

Research Excerpts

ExcerptRelevanceReference
"A fetus developed extreme supraventricular tachycardia (210/min) after intravenous hexoprenaline 10 micrograms was administered to the mother for intrapartum fetal distress."7.68Severe fetal tachycardia after administration of hexoprenaline to the mother. A case report. ( D'Hooghe, TM; Odendaal, HJ, 1991)
"A fetus developed extreme supraventricular tachycardia (210/min) after intravenous hexoprenaline 10 micrograms was administered to the mother for intrapartum fetal distress."3.68Severe fetal tachycardia after administration of hexoprenaline to the mother. A case report. ( D'Hooghe, TM; Odendaal, HJ, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Hooghe, TM1
Odendaal, HJ1

Other Studies

1 other study available for hexoprenaline and Embryopathies

ArticleYear
Severe fetal tachycardia after administration of hexoprenaline to the mother. A case report.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1991, Dec-07, Volume: 80, Issue:11-12

    Topics: Adult; Female; Fetal Diseases; Fetus; Hexoprenaline; Humans; Pregnancy; Tachycardia

1991